With a discovery that could rewrite the immunology textbooks, an international group of scientists, including the teams of Bart Lambrecht, Martin Guilliams, Hamida Hammad, and Charlotte Scott (all from the VIB-UGent Center for Inflammation Research) identified a new type of antigen-presenting immune cell.
Each year, EMBO elects promising young scientists to join its Young Investigators Programme. In 2020, Prof. Bert De Rybel (VIB-UGent Center for Plant Systems Biology) and Prof. Martin Guilliams (VIB-UGent Center for Inflammation Research) will join the ranks of these outstanding researchers.
Each year, the EU launches calls for postdoc research fellowships through the Marie Sklodowksa-Curie Actions. Fellowships provided through these actions support researchers regardless of age and nationality. Researchers working across all disciplines are eligible for funding. The prestigious two-year funding of Marie Curie fellowships attracts an enormous number of applications. Consequently, these fellowships are very competitive with a typical success rate of around 12%. VIB, however, manages to maintain a success rate of around 27%. The standing of these fellowships also provides an excellent springboard for the launch of an outstanding research career.
Established scientists with 7 – 12 years of research experience demonstrating that they can run their own labs are eligible for Consolidator Grants from the European Research Council. This funding, specifically targeting high risk/ high gain projects, totals approximately 2 million euro per scientist. In November of 2016, three of our very own top researchers, Stein Aerts (VIB-KU Leuven Center for Brain & Disease Research), Martin Guilliams (VIB-UGent Center for Inflammation Research) and Rouslan Efremov (VIB-VUB Center for Structural Biology) were awarded Consolidator Grants, bringing the total number of such ERC grants won by VIB scientists up to 43.
The European Research Council (ERC) has awarded 3 VIB scientists a consolidator grant: Stein Aerts (VIB-KU Leuven), Martin Guilliams (VIB-UGent) and Rouslan Efremov (VIB-VUB). These 'consolidator grants' are rewarded to scientists (PhD 7-12 years) who already showed that they are able to run their own lab. The European Research Council's grant allows them to anchor the start of a high risk/high gain program, feasible through this recognition of nearly 2 Mio€ per scientist.
We are in 2016, an important year for macrophages (and macrophage researchers). It has been 100 years since the death of Elie Metchnikoff who discovered macrophages: the ideal opportunity to focus on macrophage research within VIB. We had a chat with Martin Guilliams (VIB-UGent), Jo Van Ginderachter (VIB-Vrije Universiteit Brussel) and Max Mazzone (VIB-KU Leuven).